Abstract:Since the thalidomide incident, research on chiral drugs has escalated immensely. Differences in drug configuration can lead to significant variations in therapeutic efficacy. Matrine, a natural product esteemed for its low toxicity and high water solubility, has garnered significant attention in research endeavors. Nonetheless, its precise target has proven elusive. In this study, we designed and synthesized a novel chiral matrine derivative. Their cytotoxicity against three types of tumor cells was assessed. Comparing the newly synthesized derivatives to the parent matrine, most compounds exhibited significantly enhanced inhibitory effects on cancer cells. Among them, Q12 exhibited the highest activity, with IC50 values of 8.31 μM against rat glioma cells C6, 6.3 μM against human liver cancer cells HepG2 and 7.14 μM against human gastric cancer cells HGC-27, meanwhile showing low toxicity. Based on IC50 values, we constructed a preliminary structure-activity relationship (SAR). Compound Q12 significantly suppressed the cloning and migration of HepG2 cells. Further mechanistic studies indicated that Q12 inhibited Topo I in HepG2 cells, leading to DNA damage, induction of G0/G1 cell cycle arrest and ultimately causing apoptosis. The molecular docking experiments provided a rational binding mode of Q12 with the Topo I-DNA complex. In vivo, experiments demonstrated that Q12 exhibited a higher tumor growth inhibition rate (TGI) compared to the positive control drug Lenvatinib, while maintaining good safety. In summary, it suggests that Topo I might be a potential target for matrine and Q12 represents a promising candidate for cancer treatment.

Synthesis and Biological Evaluation of the Matrine Derivatives As a Novel Family of Potential Anticancer Agents

Synthesis and biological evaluation of matrine derivatives containing benzo-α-pyrone structure as potent anti-lung cancer agents

Design, Synthesis and Biological Evaluation of Matrine Derivatives As Potential Anticancer Agents.

Synthesis, Biological Evaluation and Mechanism Studies of Matrine Derivatives As Anticancer Agents.

Synthesis, Characterization And Activity Evaluation Of Matrinic Acid Derivatives As Potential Antiproliferative Agents

Synthesis, characterization and in vitro biological evaluation of two matrine derivatives

Synthesis, Characterization and in Vitro Anti-Tumor Activities of Matrine Derivatives

Design, Synthesis, and In vitro Biological Activities of Matrine Skeleton Derivatives as Potential Cancer Inhibitors

Synthesis and Biological Evaluation of Novel Hybrid Matrine Derivatives As Anticancer Agents

Synthesis of Novel Matrine Derivatives Containing Furanone Skeleton and Preliminary Evaluation of Their Anticancer Activity in Vitro

Synthesis and Biological Evaluation of Matrine Derivatives As Anti-Hepatocellular Cancer Agents.

Design, synthesis and biological evaluation of matrine-dithiocarbamate hybrids as potential anticancer agents

Design, Synthesis, and Biological Evaluation of Matrine Derivatives Possessing Piperazine Moiety As Antitumor Agents

Synthesis and Biological Evaluation of Nitric Oxide-Releasing Matrine Derivatives As Anticancer Agents

Synthesis and Anti-cancer Activity of Nitric Oxide Donor-based Matrine Derivatives

Synthesis and antitumor activity of 13-acylmatrine derivatives

Design, Synthesis and Anticancer Activity of Matrine Derivatives with Spiro

Synthesis, Biological activities, and Molecular docking Studies of 15‐site Matrine Based Isatohydrazone Derivatives as Potential Anticancer Agents

Novel chiral matrine derivatives as potential antitumor agents: Design, synthesis and biological evaluation

Synthesis and Antitumor Evaluation of a Novel Series of Triaminotriazine Derivatives.

SAR-guided development of indole-matrine hybrids as potential anticancer agents via mitochondrial stress/cytochrome c/caspase 3 signaling pathway